ArticleWorld journal of otorhinolaryngology - head and neck surgery2026
The Relationship Between Blood Lipids, Coagulation Indexes, Blood Homocysteine and Sudden Deafness: A Retrospective Study and Mendelian Randomization Analysis.
Article in World journal of otorhinolaryngology - head and neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Relationship Between Blood Lipids, Coagulation Indexes, Blood Homocysteine and Sudden Deafness: A Retrospective Study and Mendelian Randomization Analysis.World journal of otorhinolaryngology - head and neck surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Certain blood components, including blood lipids, coagulation parameters, and homocysteine, have been suggested to correlate with the incidence and prognosis of sudden sensorineural hearing loss (SSNHL). However, the nature of these associations remains controversial. Methods: A retrospective study was conducted between January 2020 and December 2024. A total of 308 patients with SSNHL who received short-term combined therapy and 169 healthy controls were included from our hospital. Initially, baseline clinical indicators were compared between the patient group and the control group. Subsequently, patients were further stratified into four subgroups according to their hearing recovery outcomes for more detailed inter-group comparisons, and the impact of these indicators on SSNHL incidence and prognosis was assessed. To further investigate potential causality, Mendelian randomization (MR) analysis was performed to examine the relationship between genetically predicted blood components and SSNHL. Results: Our retrospective analysis revealed significant differences between the patient and control groups in the following parameters at admission: plasma fibrinogen at admission (PRE-FIB), activated partial thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT), total cholesterol (CHOL), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG). Among the four groups stratified by hearing recovery, differences were observed in admission hearing level (dB), the change in plasma fibrinogen after the first batroxobin injection relative to baseline (DIFF-FIB), and CHOL. MR analysis using the random-effects inverse-variance weighted (IVW) method indicated a significant causal relationship between genetically predicted lipid levels and SSNHL. Additionally, genetically predicted S-adenosylhomocysteine and fibrinogen were identified as potential risk factors for SSNHL. Conclusions: PRE-FIB, APTT, TT, PT, CHOL, HDL-C, LDL-C, and TG may be associated with the onset of SSNHL. Admission hearing level (dB), DIFF-FIB, and CHOL could play a role in predicting hearing recovery after SSNHL. MR analysis provides causal evidence supporting lipids, fibrinogen, and S-adenosylhomocysteine as potential risk factors for SSNHL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.